Another cancer deal

  1. 1,290 Posts.
    lightbulb Created with Sketch. 174
    Astellas snaps up cancer antibody play Ganymed for up to $1.4B

    Interesting thar Ganymede is just about at the same stage as VLA, i.e. good p2 data. If anything our company is ahead, having good results in a wider range of conditions and also the combo potential
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.